SOURCE: Glycology, Inc.

October 19, 2005 10:23 ET

Glycology, Inc. to Begin Worldwide Distribution for Celsync™, the First All-Natural Nutrient, Based on Nobel Prize Science

PHILADELPHIA, PA -- (MARKET WIRE) -- October 19, 2005 -- Glycology, Inc. (OTC: GYLG)( will be expanding distribution of its lead product, Celsync™ to global markets. Celsync™ ( is the first all-natural nutrient, based on recent Noble Prize winning research (1994, 1999, 2000 and 2001) that identified cell-to-cell communications as the key to slow the aging process, improve performance and inhibit disease.

"We have begun extremely positive discussions with highly regarded distributors who want to market Celsync™ in specific countries outside of the USA," said Donna Murdoch, Glycology president. "We expect to have a worldwide distribution network and anticipate announcing our European marketing partners in the near future."

Celsync™, which is the first product to capitalize on the new science of glycobiology, is provided in 90 capsule bottles, taken one capsule three times a day. It is neither a vitamin nor a mineral, but rather an all-natural botanical that has documented healing properties coupled with the ability to enhance the positive effects of multi-vitamins and minerals.

Presently Celsync™ is sold online and domestically through retail health and natural food stores, pharmacies, and vitamin specialty shops. Domestic dealers and international distributors are encouraged to contact the company through its website at: (

About Glycology, Inc.

Glycology, Inc. ( is a lifesciences company focused on the discovery, development and marketing of nutraceutical preparations and supplements that enhance health, and well being, as well as prevent and treat a broad range of illnesses. Its flagship product Celsync™ ( is a breakthrough dietary supplement based on Nobel Prize winning research. Glycology, Inc., is the first company to capitalize on these amazing scientific breakthroughs by commercializing Celsync™ and expects to release additional products including Celsync™ based health and beauty products, as well as veterinary food supplements.

Forward-Looking Statements:

With the exception of historical information, this news release and accompanying information may include forward-looking statements that involve a number of risks and uncertainties. Actual results could differ materially from those anticipated as a result of various risks. There are numerous factors that could contribute to such differences, therefore such projected events and anticipated results are not warranties or guaranties that such events will occur or that the Company will achieve such results. For more information about this corporation and risks involved in the investment of their publicly traded shares, please see the company's website(s), and/or documents filed with the SEC, which are easily accessible in the EDGAR database system.

Contact Information